What does Brazilian legislation say? How to prepare for traveling abroad?

The sector reached growth of over 65% in 2024; the medical cannabis market reached R$ 345 million in pharmacies

How plant compounds help in managing pain, epilepsy, and multiple sclerosis

The event will take place on November 12 and 13, offering a comprehensive program on the medicinal use of the plant

Experts discuss the importance of integrativity in cannabinoid dentistry and the legal certainty of the process

With an initial investment of approximately R$106 million, the company offers sustainable innovation, quality, and pharmaceutical standards of excellence

Decree No. 4,977 published in the Official Gazette establishes guidelines for provision by the State Health agencies

Pharmaceutical Assistance Coordination evaluates proposals in a public session. The announcement of the winning company is expected in 2023, subject to appeals and disqualifications.

Agency requests that the court authorize the association to produce plant extract intended for patient treatment

Historical use of medicinal cannabis is highlighted at the launch ceremony

In Natal, on Sunday (3), lawyers, doctors, and supporters will take to the streets in favor of the decriminalization of marijuana

The 2nd edition of the Cannabis and Charity project is scheduled for July 29 at Av. Senador Casemiro da Rocha, 182 - Mirandópolis, SP

Currently, cannabis cultivation is only allowed with a court decision.

Habeas Corpus is the only legal recourse for patients wishing to use the plant for the treatment of various diseases

In Brazil alone, the medicinal market is expected to reach over R$ 600 million in 2023, according to a report by the data intelligence company Kaya Mind

“The scenario has improved for the associations, but so what?” Questions the president of the Santa Cannabis patients' association when demanding more dialogue from regulatory agencies and associations regarding the new political scenario

The plant's properties help combat free radicals and accelerate muscle recovery

We should witness changes in RDC 327, flexibility in the pharmaceutical form of products, a new resolution from CFM, but this agenda is unlikely to progress in Congress.

Cannabis-based products could generate around $61 billion by 2026 worldwide

Despite difficulties, a survey shows that in the first seven months of 2022, judicial authorizations for the cultivation and use of cannabis compounds for medicinal purposes were higher compared to the same period the previous year